EDESA BIOTECH, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $2.91 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $1.79M.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $1.44M.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$326.45K, a 1194.96% decline year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $402.42K.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$715.50K, a 4167.65% decline from fiscal 2024.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $17.59K.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$556.27K, a 163.01% decline from fiscal 2022.
- EDESA BIOTECH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $882.84K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 1 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | $3.24M derived: sum of 2 quarters · filed 2026-08-13 | $2.91M 10-Q · filed 2026-08-13 | $3.31M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $1.12M 10-Q · filed 2026-05-14 | $1.52M derived: sum of 3 quarters · filed 2026-05-14 | $1.26M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$326.45K 10-Q · filed 2026-02-13 | $75.97K derived: sum of 2 quarters · filed 2026-02-13 | -$185.53K derived: sum of 3 quarters · filed 2026-08-13 | -$1.07M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | $402.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $140.92K derived: sum of 2 quarters · filed 2026-08-13 | -$745.31K derived: sum of 3 quarters · filed 2026-08-13 | -$715.50K 10-K · filed 2025-12-12 | ||||
| 2025-06-30 | -$261.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | -$1.15M derived: sum of 2 quarters · filed 2026-08-13 | -$1.12M 10-Q · filed 2026-08-13 | -$1.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$886.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | -$856.42K 10-Q · filed 2026-05-14 | -$1.37M derived: sum of 3 quarters · filed 2026-05-14 | -$1.15M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $29.81K 10-Q · filed 2026-02-13 | -$485.64K derived: sum of 2 quarters · filed 2026-02-13 | -$262.12K derived: sum of 3 quarters · filed 2026-02-13 | -$56.05K derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-09-30 | -$515.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | -$291.93K derived: sum of 2 quarters · filed 2025-12-12 | -$85.87K derived: sum of 3 quarters · filed 2025-12-12 | $17.59K 10-K · filed 2025-12-12 | ||||
| 2024-06-30 | $223.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $429.59K derived: sum of 2 quarters · filed 2025-08-08 | $533.04K 10-Q · filed 2025-08-08 | $846.20K derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $206.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $309.52K 10-Q · filed 2025-05-14 | $622.68K derived: sum of 3 quarters · filed 2025-05-14 | $401.74K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $103.46K 10-Q · filed 2025-02-14 | $416.62K derived: sum of 2 quarters · filed 2025-02-14 | $195.67K derived: sum of 3 quarters · filed 2025-02-14 | $482.44K derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | $313.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | $92.21K derived: sum of 2 quarters · filed 2024-12-13 | $378.98K derived: sum of 3 quarters · filed 2024-12-13 | -$556.27K 10-K · filed 2024-12-13 | ||||
| 2023-06-30 | -$220.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $65.82K derived: sum of 2 quarters · filed 2024-08-09 | -$869.43K 10-Q · filed 2024-08-09 | -$4.30M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $286.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | -$648.48K 10-Q · filed 2024-05-10 | -$4.08M derived: sum of 3 quarters · filed 2024-05-10 | -$1.62M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | -$935.25K 10-Q · filed 2024-02-09 | -$4.37M derived: sum of 2 quarters · filed 2024-02-09 | -$1.91M derived: sum of 3 quarters · filed 2024-02-09 | -$338.23K derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-09-30 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$976.28K derived: sum of 2 quarters · filed 2023-12-15 | $597.02K derived: sum of 3 quarters · filed 2023-12-15 | $882.84K 10-K · filed 2023-12-15 | ||||
| 2022-06-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | $4.03M derived: sum of 2 quarters · filed 2023-08-09 | $4.32M 10-Q · filed 2023-08-09 | $4.83M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | $1.86M 10-Q · filed 2023-05-11 | $2.37M derived: sum of 3 quarters · filed 2023-05-11 | -$1.22M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $285.82K 10-Q · filed 2023-02-10 | $796.65K derived: sum of 2 quarters · filed 2023-02-10 | -$2.79M derived: sum of 3 quarters · filed 2023-02-10 | $833.34K derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | $510.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$3.08M derived: sum of 2 quarters · filed 2022-12-16 | $547.51K derived: sum of 3 quarters · filed 2022-12-16 | -$124.72K 10-K · filed 2022-12-16 | ||||
| 2021-06-30 | -$3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $36.68K derived: sum of 2 quarters · filed 2022-08-12 | -$635.55K 10-Q · filed 2022-08-12 | -$110.34K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $2.95M 10-Q · filed 2022-05-13 | $3.48M derived: sum of 3 quarters · filed 2022-05-13 | $3.87M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$672.23K 10-Q · filed 2022-02-14 | -$147.02K derived: sum of 2 quarters · filed 2022-02-14 | $250.86K derived: sum of 3 quarters · filed 2022-02-14 | $151.37K derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | $525.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $923.10K derived: sum of 2 quarters · filed 2021-12-28 | $823.61K derived: sum of 3 quarters · filed 2021-12-28 | $998.90K 10-K · filed 2021-12-28 | ||||
| 2020-06-30 | $397.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $298.39K derived: sum of 2 quarters · filed 2021-08-13 | $473.69K 10-Q · filed 2021-08-13 | -$72.85K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$99.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $75.81K 10-Q · filed 2021-05-14 | $75.81K 10-Q · filed 2020-05-15 | -$470.73K derived: sum of 3 quarters · filed 2021-05-14 | -$1.96M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $175.30K 10-Q · filed 2021-02-16 | $175.30K 10-Q · filed 2020-02-13 | -$371.24K derived: sum of 2 quarters · filed 2021-02-16 | -$1.86M derived: sum of 3 quarters · filed 2021-02-16 | -$1.71M derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | -$546.53K derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | -$2.03M derived: sum of 2 quarters · filed 2020-12-07 | -$1.89M 10-K · filed 2020-12-07 | -$1.88M 10-KT · filed 2019-12-12 | -$1.92M derived: sum of 4 quarters · filed 2020-12-07 | |||
| 2019-06-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | -$1.34M 10-Q · filed 2019-08-14 | -$1.38M 10-Q · filed 2020-08-12 | -$1.30M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $150.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $111.73K 10-Q · filed 2020-05-15 | $308.12K 10-Q · filed 2019-05-08 | $190.16K derived: sum of 3 quarters · filed 2020-05-15 | $15.34K derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$38.48K 10-Q · filed 2020-02-13 | $17.96K 10-Q · filed 2019-02-05 | $39.94K derived: sum of 2 quarters · filed 2020-02-13 | -$134.88K derived: sum of 3 quarters · filed 2020-02-13 | $79.04K 10-KT · filed 2019-12-12 | |||
| 2018-09-30 | $78.42K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$96.39K derived: sum of 2 quarters · filed 2018-11-30 | -$81.11K derived: sum of 3 quarters · filed 2019-05-08 | $172.45K 10-K · filed 2018-11-30 | ||||
| 2018-06-30 | -$174.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$4.21K 10-Q · filed 2019-08-14 | $94.03K 10-Q · filed 2018-08-08 | -$10.44K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2018-03-31 | $15.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $268.85K 10-Q · filed 2019-05-08 | $164.38K derived: sum of 3 quarters · filed 2019-05-08 | $156.34K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $253.56K 10-Q · filed 2019-02-05 | $149.10K derived: sum of 2 quarters · filed 2019-02-05 | $141.06K derived: sum of 3 quarters · filed 2019-02-05 | -$27.88K derived: sum of 4 quarters · filed 2019-02-05 | ||||
| 2017-09-30 | -$104.46K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$112.50K derived: sum of 2 quarters · filed 2018-11-30 | -$281.44K derived: sum of 3 quarters · filed 2018-11-30 | -$302.73K 10-K · filed 2018-11-30 | ||||
| 2017-06-30 | -$8.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$176.98K derived: sum of 2 quarters · filed 2018-08-08 | -$198.27K 10-Q · filed 2018-08-08 | -$240.37K derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | -$168.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | -$190.23K 10-Q · filed 2018-05-07 | -$232.32K derived: sum of 3 quarters · filed 2018-05-07 | -$9.86K derived: sum of 4 quarters · filed 2018-05-07 | ||||
| 2016-12-31 | -$21.29K 10-Q · filed 2018-02-07 | -$63.39K derived: sum of 2 quarters · filed 2018-02-07 | $159.08K derived: sum of 3 quarters · filed 2018-02-07 | -$121.77K derived: sum of 4 quarters · filed 2018-02-07 | ||||
| 2016-09-30 | -$42.10K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $180.37K derived: sum of 2 quarters · filed 2017-12-01 | -$100.48K derived: sum of 3 quarters · filed 2017-12-01 | -$33.40K 10-K · filed 2017-12-01 | ||||
| 2016-06-30 | $222.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$58.38K derived: sum of 2 quarters · filed 2017-08-09 | $8.70K 10-Q · filed 2017-08-09 | $297.38K derived: sum of 4 quarters · filed 2017-12-01 | ||||
| 2016-03-31 | -$280.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | -$213.77K 10-Q · filed 2017-05-09 | $74.91K derived: sum of 3 quarters · filed 2017-12-01 | $31.82K derived: sum of 4 quarters · filed 2017-12-01 | ||||
| 2015-12-31 | $67.08K 10-Q · filed 2017-02-06 | $355.76K derived: sum of 2 quarters · filed 2017-12-01 | $312.67K derived: sum of 3 quarters · filed 2017-12-01 | $177.21K derived: sum of 4 quarters · filed 2017-12-01 | ||||
| 2015-09-30 | $288.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $245.59K derived: sum of 2 quarters · filed 2017-12-01 | $110.14K derived: sum of 3 quarters · filed 2017-12-01 | $77.02K 10-K · filed 2017-12-01 | ||||
| 2015-06-30 | -$43.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$178.55K derived: sum of 2 quarters · filed 2016-08-09 | -$211.67K 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | -$135.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | -$168.57K 10-Q · filed 2016-05-09 | ||||||
| 2014-12-31 | -$33.12K 10-Q · filed 2016-02-08 | |||||||
| 2014-09-30 | $58.92K 10-K · filed 2016-12-14 | |||||||
| 2014-08-31 | $106.22K 10-K · filed 2016-12-14 | |||||||
| 2014-06-30 | -$30.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | -$157.31K derived: sum of 2 quarters · filed 2015-08-10 | -$224.63K 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | -$126.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | -$193.73K 10-Q · filed 2015-05-11 | ||||||
| 2013-12-31 | -$67.31K 10-Q · filed 2015-02-09 | |||||||
| 2013-08-31 | $29.31K 10-K · filed 2015-12-14 | |||||||
| 2012-08-31 | $292.17K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |